Safety of bioelectrical impedance analysis in advanced heart failure patients

2020 ◽  
Vol 43 (10) ◽  
pp. 1078-1085
Author(s):  
Luise Roehrich ◽  
Simon Suendermann ◽  
Isabell Anna Just ◽  
Jan Knierim ◽  
Johanna Mulzer ◽  
...  
2008 ◽  
Vol 14 (8) ◽  
pp. 676-686 ◽  
Author(s):  
Gaspare Parrinello ◽  
Salvatore Paterna ◽  
Pietro Di Pasquale ◽  
Daniele Torres ◽  
Antonio Fatta ◽  
...  

Biomedicines ◽  
2021 ◽  
Vol 9 (10) ◽  
pp. 1307
Author(s):  
Pietro Scicchitano ◽  
Massimo Iacoviello ◽  
Andrea Passantino ◽  
Piero Guida ◽  
Micaela De Palo ◽  
...  

The estimation of glomerular filtration rate (eGFR) provides prognostic information in patients with heart failure (HF). Bioelectrical impedance analysis may calculate eGFR (Donadio formula). The aim of this study was to evaluate the impact of the Donadio formula in predicting all-cause mortality in patients with HF as compared to Cockroft-Gault, MDRD-4 (Modification of Diet in renal Disease Study), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formulas. Four-hundred thirty-six subjects with HF (52% men; mean age 75 ± 11 years; 42% acute HF) were enrolled. Ninety-two patients (21%) died during the follow-up (median 463 days, IQR 287–669). The area under the receiver operator characteristic curve for eGFR, as estimated by Cockroft-Gault formula (AUC = 0.75), was significantly higher than those derived from Donadio (AUC = 0.72), MDRD-4 (AUC = 0.68), and CKD-EPI (AUC = 0.71) formulas. At multivariate analysis, all eGFR formulas were independent predictors of death; 1 mL/min/1.73 m2 increase in eGFR—as measured by Cockroft-Gault, Donadio, MDRD-4, and CKD-EPI formulas—provided a 2.6%, 1.5%, 1.2%, and 1.6% increase, respectively, in mortality rate. Conclusions. eGFR, as calculated with the Donadio formula, was an independent predictor of mortality in patients with HF as well as the measurements derived from MDRD4 and CKD-EPI formulas, but less accurate than Cockroft-Gault.


1995 ◽  
Vol 29 (11) ◽  
pp. 1091-1095 ◽  
Author(s):  
Eugene L Coodley ◽  
Jack L Segal ◽  
David Hg Smith ◽  
Joel M Neutel

Objective: To compare changes in bioimpedance parameters and calculated total body water (TBW) with conventional measurements used to assess the efficacy of diuretic therapy in the treatment of heart failure. Setting: A Veterans Affairs tertiary care, teaching hospital. Subjects: Twelve patients with New York Heart Association (NYHA) class HI congestive heart failure (CHF). Design: Prospective, consecutive sample, cohort, open label. Interventions: Parenterally administered furosemide; clinically dictated, outcome-oriented, adjunctive therapy of CHF. Outcomes: Bioelectrical impedance analysis (BIA) parameters, measured volume of diuresis and changes in body weight, defined clinical endpoints (NYHA criteria). Results: Three days of diuretic therapy with furosemide (oral and/or intravenous) for CHF was associated with a measured weight loss of 4.1 ± 0.6 kg and statistically significant increases in resistance and reactance of 20.8% ± 2.7% and 22.7% ± 6.1%, respectively (p < 0.005). Calculated TBW using BIA parameters and standard equations decreased on average by 6.1 ± 0.6 L or 11.2% ± 1.1% (p < 0.001). A significant inverse correlation was observed between change in measured body weight and total body reactance (p = 0.02). Conclusions: Single-frequency BIA appears to have limited clinical usefulness as a method of assessing diuretic therapy in the management of CHF. Its greatest usefulness appears to lie in the assessment of serial changes in individual patients and patient populations that are physiologically or metabolically homogeneous. Further studies are needed to establish the validity of BIA in patients with decompensated CHF.


Sign in / Sign up

Export Citation Format

Share Document